Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease
Authors:
Open Access
- 18 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Ginseng Research
- Vol. 47 (1) , 54-64
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Protective effects of icariin-mediated SIRT1/FOXO3 signaling pathway on intestinal ischemia/reperfusion-induced acute lung injuryMolecular Medicine Reports, 2014
- Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individualsMetabolomics, 2014
- Safety of TNF-α inhibitors during IBD pregnancy: a systematic reviewBMC Medicine, 2013
- Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North IndiaWorld Journal of Gastroenterology, 2013
- Confocal Laser Endomicroscopy in the Study of Colonic Mucosa in IBD Patients: A ReviewGastroenterology Research and Practice, 2012
- Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical ApplicationsJournal of Ginseng Research, 2012
- Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP StudyAnalytical Methods, 2011
- Jeotgalicoccus nanhaiensis sp. nov., isolated from intertidal sediment, and emended description of the genus JeotgalicoccusInternational Journal of Systematic and Evolutionary Microbiology, 2011
- COMPANION ANIMALS SYMPOSIUM: Development of the mammalian gastrointestinal tract, the resident microbiota, and the role of diet in early life1Journal of Animal Science, 2011
- Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitisClinical and Experimental Immunology, 2003